NCT01803633Active, not recruiting
Determine How Consumption of Dairy Fat as Cheese Influences Inflammation-Phase 2
Effects of Dairy Fat on Postprandial Inflammation- Phase 2
Source: ClinicalTrials.gov · Last updated 15 Dec 2025
Brief summary (registry, in English)
Phase 2 of this study involves determining how consumption of cheese compared with a non-dairy cheese substitute influences inflammation over a six hour period.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 28 Feb 2013
- Start date
- Sept 2012
- Primary completion date
- Aug 2013
- Lead sponsor
- University of California, Davis
- Diseases
- Obesity
- NCT number
- NCT01803633
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From Sept 2012 to the primary completion date, Aug 2013
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of corticoid steroids within the last 12 weeks
- Daily use of anti-inflammatory pain medication
- Dietary supplements consisting of concentrated soy isoflavones, resveratrol, other polyphenols identified as modulators of inflammation Medications
- Initiation of statin therapy within the last 12 weeks Lifestyle
Other illness
- Metabolic Disorders:
- Any immune related diseases such as autoimmune disease, rheumatoid arthritis, asthma,
- Gastrointestinal disorders including Crohn's Disease, colitis, diverticulitis, irritable bowel disease, celiac, malabsorption syndrome
- Cancer
- Known presence of significant metabolic disease which could impact the results of the study (i.e. hepatic, renal disease)
- Type II diabetes
- Self report of eating disorder
- Known allergy or intolerance to study food (lactose intolerance, dairy, wheat allergies)
Other
- BMI \> 40
- Body weight more than 400 lbs.
- Use of over-the-counter anti-obesity agents (e.g. containing phenylpropanolamine, ephedrine, and/or caffeine) within the last 12 weeks
- Poor vein assessment determined by WHNRC's phlebotomist
- Dietary/supplements:
- Vegetarian (defined as abstinence from consumption of eggs, dairy, poultry, beef and pork)
- More than 1 serving of fish per week
- More than 14 grams of fiber per 1000 kcal per day
- Less than 16:1 of total dietary omega 6: Omega 3 ratio
- More than 1% of daily energy as trans fats
- Initiation of anti-inflammatory supplemental fish, krill, flax, borage and primrose seed oils within the last 12 weeks
- More than 10% weight loss or gain during the past 6 months
- Recent initiation (past 4 weeks) of exercise program
- Plan to become pregnant in the next 6 months
- Pregnancy or lactation
- Recent initiation or cessation of hormonal birth control or change in hormonal birth control regimen within the last 12 weeks
- Use of tobacco products
- More than 2 standard alcoholic drinks per day.
Who the study is looking for
- Age 18-65 years
- Two or more components of metabolic syndrome:
- Central obesity (waist circumference greater than 40 inches for men and 35 inches for women); fasting blood triglycerides greater than or equal to 150 mg/dL; plasma HDL cholesterol (Less than 40 mg/dL for men and less than 50 mg/dL for women); blood pressure greater than or equal to 130/85 mmHg; fasting glucose greater than or equal to 100 mg/dL
- or
- \- BMI equal to or greater than 30
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| USDA Western Human Nutrition Research Center Coordinator of this site? Confirm its status | Davis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.